Search Results - "Chau Pham, Tran Minh"

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam by Pham, Van Luan, Le, Tuan Anh, Pham, Cam Phuong, Hoa Nguyen, Thi Thai, Do, Anh Tu, Nguyen, Tuan Khoi, Nguyen, Minh Hai, Thu Hoang, Thi Anh, Hao Vuong, Dinh Thy, Tam Nguyen, Dac Nhan, Khiem Dang, Van, Nguyen, Thi Oanh, Trang Vo, Thi Huyen, Do, Hung Kien, Vu, Ha Thanh, Nguyen, Thi Thuy Hang, Pham, Van Thai, Trinh, Le Huy, Dung Nguyen, Khac, Nguyen, Hoang Gia, Truong, Cong Minh, Chau Pham, Tran Minh, Nguyen, Thi Bich Phuong

“…Afatinib is indicated for advanced-stage non-small-cell lung cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) and uncommon mutations. However,…”
Get full text

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam by Pham, Cam Phuong, Nguyen, Thi Thai Hoa, Do, Anh Tu, Nguyen, Tuan Khoi, Hoang, Thi Anh Thu, Le, Tuan Anh, Vuong, Dinh Thy Hao, Nguyen, Dac Nhan Tam, Dang, Van Khiem, Nguyen, Thi Oanh, Pham, Van Luan, Nguyen, Minh Hai, Vo, Thi Huyen Trang, Do, Hung Kien, Vu, Ha Thanh, Nguyen, Thi Thuy Hang, Pham, Van Thai, Trinh, Le Huy, Nguyen, Khac Dung, Nguyen, Hoang Gia, Truong, Cong Minh, Pham, Tran Minh Chau, Nguyen, Thi Bich Phuong

“…This study aimed to evaluate the efficacy and side effects of first-line afatinib treatment in a real-world setting in Vietnam. This retrospective study was…”
Get full text

Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study by Do, Tu Anh, Nguyen, Hoa Thi Thai, Pham, Phuong Cam, Nguyen, Khoi Tuan, Hoang, Thu Thi Anh, Le, Anh Tuan, Vuong, Hao Dinh Thy, Nguyen, Tam Dac Nhan, Dang, Khiem Van, Nguyen, Oanh Thi, Pham, Luan Van, Nguyen, Hai Minh, Vo, Trang Thi Huyen, Kien, Do Hung, Vu, Thanh Ha, Nguyen, Hang Thi Thuy, Pham, Thai Van, Trinh, Huy Le, Nguyen, Gia Hoang, Truong, Minh Cong, Pham, Chau Tran Minh, Nguyen, Phuong Thi Bich

“…Afatinib, a second-generation epidermal growth factor receptor(EGFR) tyrosine kinase, has proven effective for non-small-cell lung cancer (NSCLC) patients with…”
Get more information